Evidence map›Paper›PMID 30406439›Full record

ReviewMolecular biotechnology2019

In-Silico Bioprospecting: Finding Better Enzymes.

Asmita Kamble, Sumana Srinivasan, Harinder Singh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  13. Article
  14. Article
  15. ThermophilicFrontiers in microbiology · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Asmita KambleDepartment of Biological Sciences, Sunandan Divatia School of Science, NMIMS Deemed to be University, Vile Parle (W), Mumbai, 400056, India.
Sumana SrinivasanBiosystems Engineering Lab, Department of Chemical Engineering, IIT Bombay, Powai, Mumbai, 400076, India.
Harinder SinghDepartment of Biological Sciences, Sunandan Divatia School of Science, NMIMS Deemed to be University, Vile Parle (W), Mumbai, 400056, India. Harinder.Singh@nmims.edu.ORCID http://orcid.org/0000-0001-9373-8386

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes are essential biological macromolecules, which catalyse chemical reactions and have impacted the human civilization tremendously. The importance of enzymes as biocatalyst was realized more than a century ago by eminent scientists like Kuhne, Buchner, Payen, Sumner, and the last three decades has seen exponential growth in enzyme industry, mainly due to the revolution in tools and techniques in molecular biology, biochemistry and production. This has resulted in high demand of enzymes in various applications like food, agriculture, chemicals, pharmaceuticals, cosmetics, environment and research sector. The cut-throat competition also pushes the enzyme industry to constantly discover newer and better enzymes regularly. The conventional methods to discover enzymes are generally costly, time consuming and have low success rate. Exploring the exponentially growing biological databases with the help of various computational tools can increase the discovering process, with less resource consumption and higher success rate. Present review discusses this approach, known as in-silico bioprospecting, which broadly involves computational searching of gene/protein databases to find novel enzymes.

Indexed as

BioprospectingComputer SimulationEnzymesBiotechnologyEnzymesBioprospectingEnzymeIn-silico

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.